Effectiveness and long-term safety of thiazolidinediones and metformin in renal transplant recipients

Endocrine Practice

Volumn 14, Issue 8, 2008, Pages 979-984

  Kurian, Binumol ^a   Joshi, Renu ^b   Helmuth, Amy ^b  

^a Caritas Christi Hospital   (United States)

^b Pinnacle Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CREATININE; HEMOGLOBIN A1C; METFORMIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIOGLITAZONE; PREDNISONE; TACROLIMUS; ANTIDIABETIC AGENT;

ADULT; ARTICLE; CALCULATOR; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG MONITORING; DRUG SAFETY; EDEMA; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT VERSUS HOST REACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFORMATION PROCESSING; KIDNEY TRANSPLANTATION; LIVER FUNCTION; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; DIABETES MELLITUS; MIDDLE AGED; PATHOLOGY; TIME;

DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY TRANSPLANTATION; MALE; METFORMIN; MIDDLE AGED; RETROSPECTIVE STUDIES; THIAZOLIDINEDIONES; TIME FACTORS;

EID: 65849422528     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.8.979     Document Type: Article

References (20)

1. First MR, Gerber DA, Hariharan S, Kaufman DB, Shapiro R. Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation. 2002;73:379-386.
2. Schmekal B, Biesenbach G, Janko O. Impact of kidney transplantation on glycemic control and cardiovascular risk factors in insulin-treated diabetic patients receiving cyclosporine: a longitudinal study. Transplant Proc. 2004;36:3012-3015.
3. Roozbeh J, Mehdizadeh AR, Razmkon A, Malek-Hosseini SA. Incidence of posttransplantation diabetes mellitus in kidney transplantation: a single-center experience. Transplant Proc. 2005;37:3095-3097.
4. Mathew JT, Rao M, Job V, Ratnaswamy S, Jacob CK. Post-transplant hyperglycemia: a study of risk factors. Nephrol Dial Transplant. 2003;18:164-171.
5. Markell M. New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management. Am J Kidney Dis. 2004;43:953-965.
6. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care. 2002;25:583-592.
7. Salvadori M, Bertoni E, Rosati A, Zanazzi M. Post-transplant diabetes mellitus. J Nephrol. 2003;16:626-634.
8. Davidson J, Wilkinson A, Dantal J, et al; International Expert Panel. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 2003;75:SS3-SS24.
9. Kim H, Cheigh JS. Kidney transplantation in patients with type 1 diabetes mellitus: long-term prognosis for patients and grafts. Korean J Intern Med. 2001;16:98-104.
10. Ramanathan V, Goral S, Tanriover B, et al. Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation. Transplantation. 2005;79:453-458.
11. Munson JL, Bennett WM, Barry JM, Norman DJ. A case control study of renal transplantation in patients with type I diabetes. Clin Transplant. 1992;6:306-311.
12. Wyzgał J, Paczek L, Sańko-Resmer J, et al. Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors. Ann Transplant. 2007;12:26-29.
13. Pham PT, Pham PC, Lipshutz GS, Wilkinson AH. New onset diabetes mellitus after solid organ transplantation. Endocrinol Metab Clin North Am. 2007;36:873-890.
14. Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005;65:385-411.
15. Luther P, Baldwin D Jr. Pioglitazone in the management of diabetes mellitus after transplantation. Am J Transplant. 2004;4:2135-2138.
16. Voytovich MH, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmann A. Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients. Nephrol Dial Transplant. 2005;20:413-418.
17. Pietruck F, Kribben A, Van TN, et al. Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation. Transpl Int. 2005;18: 483-486.
18. Villanueva G, Baldwin D. Rosiglitazone therapy of post-transplant diabetes mellitus. Transplantation. 2005;80: 1402-1405.
19. Goldberg PA. Comprehensive management of post-transplant diabetes mellitus: from intensive care to home care. Endocrinol Metab Clin North Am. 2007;36:907-922.
20. Fadem, Stephen Z. MDRD GFR Calculator (With SI Units). Nephron Information Center, National Kidney Foundation. http://www.kidney.org/ professionals/kdoqi/ gfr-calculator.cfm. Accessed May 5, 2008.